WESTMINSTER, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 200,000 Mobi-C Cervical Discs ...

Healthcare investment company ARCHIMED's affiliate is set to acquire ZimVie, a life sciences company focusing on the dental implant market, for an enterprise value of around $730m. According to the ...

ZimVieZIMV shares catapulted by triple digits Monday after the dental implants maker agreed to a $730 million takeover deal. The deal will see ZimVie be acquired by private equity firm Archimed for ...

WESTMINSTER, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 2,000 children worldwide have ...

PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's ...

ZimVie (NASDAQ:ZIMV) is set to give its latest quarterly earnings report on Wednesday, 2024-10-30. Here's what investors need to know before the announcement. Analysts estimate that ZimVie will report ...

Recently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per shareNet Sales from Continuing Operations of $116.7 millionNet Loss from Continuing Operations of $(3.8) ...

ZimVie Inc. ZIMV recently launched its RealGUIDE Software Suite and Implant Concierge service in Japan. The RealGUIDE platform enables streamlined workflows and enhanced treatment accuracy, while the ...

PALM BEACH GARDENS, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for ...

ZimVie, which specializes in devices and technology for the spine and dental segments, reported its fourth-quarter and full-year 2022 earnings after market hours on Wednesday. These revealed that the ...

Dentsply Sirona (NASDAQ:XRAY) and ZimVie Inc. (NASDAQ:ZIMV) show below-market growth and have no meaningful upside, according Needham analysts. What Happened: Needham downgraded the two dental ...